CN Stock MarketDetailed Quotes

688578 Shanghai Allist Pharmaceuticals Co., Ltd.

Watchlist
  • 61.13
  • +3.40+5.89%
Market Closed Nov 29 15:00 CST
27.51BMarket Cap21.21P/E (TTM)

About Shanghai Allist Pharmaceuticals Co., Ltd. Company

The company is headquartered in Zhoupu Medical Park in Shanghai. It was founded in March 2004 by entrepreneur Mr. Du Jinhao and Dr. Guo Jianhui, who has the honor of being a lifelong scientist from the US National Institutes of Health (NIH). Iris is an innovative pharmaceutical company integrating R&D, production and marketing. It is committed to developing and producing innovative drugs with independent intellectual property rights, safe, effective and beneficial to the public, with the development concept of Chinese innovation and caring for global patients, guided by the unmet clinical needs of the global pharmaceutical market, focusing on the field of cancer treatment, with the goal of developing first-in-class drugs (first-in-class) and best-in-class drugs (best-in-class). The company is an innovative drug enterprise focusing on the field of tumor treatment, and has now built an advantageous R&D pipeline in the field of small molecule targeted drugs for non-small cell lung cancer (NSCLC). The main products are vometinib mesylate tablets and platinib capsules. Corporate honors: “Pharmaceutical Innovation Achievement Award of the Year”, “2020 Ji World Cup Top Ten Pharmaceutical Innovation Emerging Companies of the Year”, “Top 10 Best Biomedical Listed Companies”, and 2021 China Pharmaceutical Emerging Innovation Force Enterprise. The company won honorary titles such as “2020 World Cup Top Ten Pharmaceutical Innovation Emerging Companies” hosted by the Securities Times, “Top 10 Best Biomedical Listed Companies” in the 2020 China Healthcare Industry Investment and Financing Glory List, 2021 China Pharmaceutical Emerging Innovation Power Enterprise, etc., and also joined the “China Pharmaceutical Innovation Promotion Association Member”, “Pharmaceutical Innovation 100 Alliance Founding Board Member”, and “2022 Shanghai Top 100 Hard Core Enterprises”, and continues to demonstrate its hard-core strength. The chairman of the company, Mr. Du Jinhao, won the “EY Entrepreneur Of The Year Award” in 2022.

Company Profile

Short Name-A艾力斯医药科技
Company NameShanghai Allist Pharmaceuticals Co., Ltd.
Listing DateDec 2, 2020
Issue Price22.73
Shares Offered90.00M share(s)
FoundedMar 22, 2004
Chairmanjinhao du
Legal Representativejinhao du
General Managerjinhao du
Secretaryshuo li
Employees1044
ProvinceShang Hai Shi
Phone021-80423292
Office AddressNo. 268, Lingxiaohua Road, Zhoupu Town, Pudong District, Shanghai
Zip Code201318
Registered AddressNo. 268, Lingxiaohua Road, Zhoupu Town, Pudong District, Shanghai
Fax021-80423291
EmailIR@allist.com.cn
Business License91310115759595927U
BusinessThe issuer is an innovative drug company focusing on the field of tumor treatment, and has now built a rich R&D pipeline in the field of small-molecule targeted drugs for non-small cell lung cancer.

Company Executives

  • Name
  • Position
  • Salary
  • jinhao du
  • Chairman, Directors
  • 3.53M
  • JEFFREY YANG GUO
  • Directors
  • --
  • cong xu
  • Directors
  • --
  • ju qi
  • Directors
  • --
  • jie hu
  • Directors, Deputy General Manager
  • 2.21M
  • ronggang xie
  • Directors
  • --
  • jun yan
  • Independent Directors
  • 96.00K
  • chao lv
  • Independent Directors
  • 96.00K
  • shengtao zhu
  • Independent Directors
  • 96.00K
  • jiayu yang
  • Independent Directors
  • 96.00K
  • shuo li
  • Board Secretary
  • 958.90K
  • shuwen wang
  • Securities Affairs Representative
  • --
  • shengming chu
  • Auditors
  • 296.10K
  • feng xu
  • Deputy General Manager
  • 2.06M
  • lin wang
  • Head of Finance
  • 1.19M
  • huayong zhou
  • Core technical personnel, Deputy Director of R&D
  • --
  • yong jiang
  • Core Technical Personnel
  • --
  • qiang zhang
  • Core Technical Personnel
  • 243.10K
  • qing li
  • Core Technical Personnel
  • 227.40K
  • chunqing liang
  • Core Technical Personnel
  • 166.20K
  • huibing luo
  • Core Technical Personnel
  • 1.78M
  • jingtian xie
  • Core Technical Personnel, Formulation Department Manager
  • --
  • huafeng dan
  • Chief Quality Officer
  • 1.28M
  • chen huang
  • Head of Marketing
  • 1.83M
  • guilian ceng
  • Chief Operating Officer (COO)
  • 289.90K
  • lijun wang
  • Employee Supervisors
  • 194.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data